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SpainObjectives: The aim of this study was to determine the effects of escalation of respiratory support and prolonged postoperative invasive ventila-
tion on patient-centered outcomes, and identify perioperative factors associated with these 2 respiratory complications.
Design: A retrospective cohort analysis of cardiac surgical patients admitted to the cardiothoracic intensive care unit (ICU) between August
2015 and January 2018. Escalation of respiratory support was defined as “unplanned continuous positive airway pressure,” “non-invasive ven-
tilation,” or “reintubation” after surgery; prolonged invasive ventilation was defined as “invasive ventilation beyond the first 12 hours following
surgery.” The primary endpoint was the composite of escalation of respiratory support and prolonged ventilation.
Setting: Tertiary cardiothoracic ICU.
Participants: A total of 2,098 patients were included and analyzed.
Interventions: None.
Measurements and Main Results: The composite of escalation of support or prolonged ventilation occurred in 509 patients (24.3%). Patients
who met the composite had higher mortality (2.9% v 0.1%; p < 0.001) and longer median [interquartile range] length of ICU (2.1 [1.0-4.9] v 0.9uests to Vasileios Zochios, MD, University Hospitals of Leicester National Health Service Trust, Department of Anesthesia and Intensive
eld Hospital, Groby Rd, Leicester LE3 9QP, UK.
asileioszochios@doctors.org.uk (V. Zochios).
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V. Zochios et al. / Journal of Cardiothoracic and Vascular Anesthesia 34 (2020) 12261234 1227[0.8-1.0] days; p < 0.0001) and hospital (10.6 [8.0-16.0] v 7.2 [6.2-10.0] days; p < 0.0001) stay. Hypoxemia and anemia on admission to ICU
were the only 2 factors independently associated with the need for escalation of respiratory support or prolonged invasive ventilation.
Conclusions: Escalation of respiratory support or prolonged invasive ventilation is frequently seen in cardiac surgery patients and is highly asso-
ciated with increased mortality and morbidity. Hypoxemia and anemia on admission to the ICU are potentially modifiable factors associated with
escalation of respiratory support or prolonged invasive ventilation.
 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/)
Key Words: cardiac surgery; postoperative pulmonary complications; pulmonary morbidity; invasive ventilationA NEW consensus definition of “postoperative pulmonary
complications” has been recently proposed by the Standard-
ized Endpoints for Perioperative Medicine (StEP) Collabora-
tion.1 This consensus definition consists of 4 rather subjective
pulmonary outcome measures, namely atelectasis, pneumonia,
aspiration, and the acute respiratory distress syndrome.1,2 The
StEP Collaboration also introduced a concept of “severity” of
pulmonary complications after surgery, which may reduce the
subjectivity of the definition.1,2 In their consensus, severity is
classified as “severe” when a patient needs escalation of respi-
ratory support, defined as “unplanned continuous positive air-
way pressure” (CPAP), “unplanned non-invasive ventilation”
(NIV), or “reintubation and invasive ventilation.”1
As with other major surgeries, cardiac surgery is associated
with postoperative pulmonary morbidity associated with adverse
clinical outcomes such as increased mortality and prolonged hos-
pital stay, and also increased healthcare utilization costs.3,4 Post-
operative pulmonary complications in the context of cardiac
surgery have been poorly defined and cardiac surgery-specific
factors such as the use of cardiopulmonary bypass and apnea
during cardiopulmonary bypass, intraoperative manipulation of
the lungs and thoracic cage, and midline sternotomy appear to
increase the risk for pulmonary complications after surgery.5,6
The StEP Collaboration approach has not yet been explored in a
cardiac surgical population.3,4 The current study aimed to quantify
the rate of escalation of respiratory support (as defined by StEP
Collaboration for “severe” pulmonary complications) or prolonged
postoperative invasive ventilation (not used by the StEP Collabora-
tion, but yet another frequent and unwanted respiratory complica-
tion after cardiac surgery), and to determine their relationship with
mortality and morbidity. In addition, perioperative factors predic-
tive of escalation of respiratory support or prolonged invasive ven-
tilation were identified. Establishing the severity of respiratory
complications after cardiac surgery, and potentially modifiable
risk factors associated with their development, will eventually
allow development and evaluation of mitigation strategies. The
authors’ null hypothesis was therefore that StEP-defined severe
postoperative pulmonary complications and prolonged postopera-
tive invasive ventilation are not associated with adverse outcomes
of mortality and intensive care unit (ICU) length of stay.Methods
The authors retrospectively examined a cohort of adult car-
diac surgical patients who underwent elective cardiac surgerywith cardiopulmonary bypass (first-time coronary artery
bypass grafting, valve surgery or combined coronary artery
bypass with valve surgery) and were admitted to Royal Pap-
worth Hospital National Health Service (NHS) Trust cardio-
thoracic ICU (a leading heart and lung center in
Cambridgeshire, UK, and one of the largest specialist cardio-
thoracic hospitals in Europe) between August 2015 and Janu-
ary 2018. The study period was selected based on the fact that
there were no changes to standard patient management proce-
dures during this period, minimizing a potentially significant
source of bias. Patients who underwent redo-sternotomy, post-
cardiotomy cardiac or respiratory extracorporeal membrane
oxygenation, or other procedures (“off pump” surgery, aortic
root surgery, heart or lung transplantation, septal defect sur-
gery, and vascular reconstruction) were excluded.
The analysis and reporting adhered to the Strengthening the
Reporting of Observational Studies in Epidemiology
(STROBE) statement.7 The project proposal was reviewed and
approved by the Royal Papworth Hospital NHS Foundation
Trust Research and Development board (S02402, correspon-
dence March 3, 2018), it was deemed to have no material ethi-
cal issues and written informed consent was not a requirement.
All data were depersonalized and anonymized.
Data was collected via the perioperative surgical and ICU
electronic clinical information systems and the local clinical
audit and research data system.
Escalation of respiratory support was defined as described
by the StEP Collaboration1 as follows:
1. Need for unplanned postoperative use of CPAP, or
2. Need for unplanned postoperative NIV, or
3. Need for reintubation and invasive ventilation.
Prolonged invasive ventilation was defined as need for inva-
sive ventilation beyond 12 hours after surgery.8-10
Intensive care unit and hospital mortality were defined as
death during the time they were in the ICU or in the hospital.
Length of stay in ICU was defined as time between point of
entry to the ICU to discharge back to the cardiac surgery ward,
or time of mortality in ICU if this occurred. Hospital length of
stay refers to the day of surgery to the last day in hospital alive.
The local intraoperative and postoperative strategies during
the study period were not rigid, but comprised strong advice to
use tidal volumes of 6 to 8 mL/kg1 predicted body weight;
positive end-expiratory pressure (PEEP) level of 5 cmH2O
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sation of mechanical ventilation and zero PEEP during cardio-
pulmonary bypass.11 The intraoperative red cell transfusion
threshold was 70 g/L. Postoperative management in the ICU
consisted of cardiac monitoring and optimization of hemody-
namics. Weaning of ventilatory support, transition from assist
ventilation to spontaneous ventilation, and extubation were con-
ducted when patients met appropriate criteria, namely normo-
thermia, absence of bleeding, established regular spontaneous
respiratory pattern, hemodynamic stability, and no residual neu-
romuscular blockade or abnormal neurologic findings.
Decisions to escalate respiratory support or to continue inva-
sive mechanical ventilation were at the discretion of the
attending intensivist. High-flow nasal oxygen therapy was
used only seldomly at the time of this study.
Baseline patient characteristics including sex, age, weight,
height, body mass index, type of cardiac surgery, logistic, and
additive European System for Cardiac Operative Risk Evalua-
tion (EuroSCORE)12 were extracted from the electronic clini-
cal information system and the local clinical audit and
research data system. Perioperative data (cardiopulmonary
bypass time, cross-clamp time, and duration of invasive venti-
lation) were derived from the local clinical audit and research
data system. Hemoglobin levels and ratio of arterial partial
pressure of oxygen to inspired fraction of oxygen on admission
to ICU were extracted from the electronic clinical information
system. Escalation of respiratory support in the first 5 postop-
erative days, survival, and length of stay data were derived
from the local electronic clinical information, clinical audit,
and research data systems.
The primary endpoint of the study was the composite of
“need for escalation of respiratory support” and “prolonged
invasive ventilation.” The composite of postoperative escala-
tion of respiratory support, as defined by StEP collaboration
and prolonged invasive ventilation, was chosen as the primary
endpoint as it integrates both intraoperative (eg, ventilator-
induced lung injury, transfusion-associated lung injury, and
transfusion-associated circulatory overload) and postoperative
complications (eg, atelectasis); the authors’ composite out-
come is therefore a “non-mortality” outcome reflecting quality
of perioperative care, which makes it more meaningful to
patients, healthcare providers, and the public than specific
physiological pulmonary outcomes or individual postoperative
pulmonary complications.1,2,13
Secondary outcomes were the risk of mortality and length of
stay in the ICU and hospital. Other outcomes were mediating
perioperative factors contributing to the primary outcome.
Statistical Analysis
Where appropriate, continuous data between groups were
compared using either the Student’s t test (mean comparison)
or Wilcoxon rank sum (median comparison), and categorical
data were compared using x2 tests. Where dependent variables
were continuous, an adjusted generalized linear regression
model was used to assess the impact of a unit of change per
dependent variable described as a regression coefficient.Alternatively, where dependent variables were binary an
adjusted logistic regression was conducted to assess the unit of
change as an odds ratio (OR). The composite outcome consist-
ing of patients who required escalation of respiratory support
or prolonged invasive ventilation was described using the fre-
quency of patients rather than treated as separate events to pre-
vent multiple counting of the same individual (eg, to prevent
individuals who were intubated for over 12 hours and required
postextubation CPAP being counted twice).
Time dependent data, such as “time to extubation” and lengths
of ICU and hospital stay, were presented using KaplanMeier
analyses comparing patients who required escalation of respira-
tory support or prolonged invasive mechanical ventilation
against those who did not require these interventions.
Risk factors were identified contributing to the development
of either a requirement for escalation of respiratory support or
prolonged invasive ventilation. The models identifying risk
factors were developed in accordance with transparent report-
ing of a multivariable prediction model for individual progno-
sis or diagnosis guidelines.14 Potential risk factors based on
demographic and physiological data were prespecified based
on a review of the literature and data availability. An unad-
justed association between potential risk factors and need for
escalation of respiratory support or prolonged invasive ventila-
tion was assessed using univariate logistic regression. A liberal
p value threshold of <0.15 was set as the cut-off point after
univariate regression to select variables for inclusion in the
multiparametric model. Statistical significance in the multivar-
iate model was set at a p value <0.05. Where missing data
were present in variables of interest, a complete-case analysis
was conducted when developing the regression model, as very
few cases had any missing data (n = 9).
After development of a regression model, the multivariate
model was internally assessed using bootstrap methods. Each
model created was validated on 100 replications using the boot-
strap method. These results were then visually compared to the
main analysis to assess for any differences in performance.
All analyses were performed using Stata version 14.2 soft-
ware (StataCorp LLC, College Station, TX). A p value <0.05
was considered statistical significance.Results
Study Population
Of 4,732 patients admitted, 2,098 patients met the inclusion
criteria (Fig 1). Baseline characteristics and outcomes are pre-
sented in Tables 1 and 2. The majority of patients was male
and underwent coronary artery bypass graft surgery. The
median (interquartile range) time to extubation was 6.1 (4.0-
11.0) hours.Escalation of Respiratory Support or Prolonged Invasive
Ventilation
Rate of escalation of respiratory support in the first 5 postop-
erative days was 7.3% and rate of prolonged invasive
Table 1
Patient Characteristics
Patient Characteristics Study Cohort (n = 2,098)
Age (y) 69.8 (10.7)
Sex
Male 1,498 (71.4%)
Height (m) 1.70 (0.10)
Weight (kg) 82 (71-93)
BMI (kg/m2) 28.5 (5.2)
Hemoglobin (g/L) 103.4 (15.9)
Logistic EuroSCORE 4.0 (2.1-7.5)
Additive EuroSCORE 5 (3-7)
Time to extubation (h) 6.14 (4.04-11.02)
Surgical characteristics
Type of surgery
CABG 919 (43.8%)
Valve surgery 786 (37.5%)
CABG and valve surgery 393 (18.7%)
Cardiopulmonary bypass time (min) 85 (68-105)
Cross-clamp time (min) 57 (44-72)
NOTE. Data are mean (standard deviation), number (%), or median
(interquartile range).
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft;
EuroSCORE, European System for Cardiac Operative Risk Evaluation.
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escalation of respiratory support or prolonged invasive ventila-
tion was 24.3%.
Patients who met the composite had a longer median time to
extubation (23 [14-61] v 5 [3-7] hours; p < 0.0001), longer
median ICU (2.1 [1.0-4.9] v 0.9 [0.8-1.0] days; p < 0.0001) and
hospital (10.6 [8.0-16.0] v 7.2 [6.2-10.0] days]; p < 0.0001)
stay (Table 3, Fig 2). A subgroup analysis is presented in sup-
plementary material section (Fig 3) where the composite group
is broken down into patients who required escalation of respira-
tory support and patients who received prolonged invasive ven-
tilation. “Time to extubation,” “time to discharge from ICU,”
and “time to discharge from hospital” was longer in patients
with either complication.
After adjusting for possible confounding factors, including
EuroSCORE, cardiopulmonary bypass time, age, gender, body
mass index, cross-clamp time, ICU admission hemoglobin
level, admission arterial partial pressure of oxygen to inspired
fraction of oxygen ratio, and type of surgery, there was a sig-
nificant between-group difference in length of ICU stay
(regression coefficient 3.0 [95% confidence interval, 1.3-4.8]),
hospital length of stay (regression coefficient 10.0 [95% confi-
dence interval, 5.8-14.3]), and in-hospital mortality (2.9% v
0.1%; p < 0.001).Risk Factors for Escalation of Respiratory Support or
Prolonged Invasive Ventilation
The results of the unadjusted univariate logistic regression
are summarized in Tables 4 and 5. Additional data on levels of
oxygenation and internal validation using bootstrap replicationFig 1. Flow diagram oare shown in supplementary material (Appendix A, Supple-
mental Tables 1-3).15 Multivariable adjustment showed that
the hemoglobin level (OR 0.98 [0.97-0.99]; p = 0.002) and the
arterial partial pressure of oxygen to inspired fraction of oxy-
gen ratio (OR 0.92 [0.90-0.94]; p < 0.001) directly after sur-
gery were significant risk factors for subsequent escalation of
respiratory support. These factors remained congruent after
bootstrap validation.f study population.
Table 2
The Occurrence of Escalation of Respiratory Support and Prolonged Invasive
Ventilation Within the First 5 Postoperative Days
Outcome
Frequency of Event
(n = 2,098) Percentage (%)
CPAP/NIV 126 6.0
Reintubation 40 1.9
Prolonged invasive ventilation
(>12 h)
478 23
Composite outcome groups
Escalation of respiratory support
(requiring CPAP/NIV or
reintubation and invasive
ventilation-StEP defined severe
pulmonary complications)
154 7.3
Escalation of respiratory support
(requiring CPAP/NIV or
reintubation and invasive
ventilation) and/or prolonged
invasive ventilation (>12 h)
510 24.3
NOTE. Data are frequencies of patients experiencing the outcomes and
percentages (the composite outcome consisting of patients who required
escalation of respiratory support or prolonged invasive ventilation was
described using the frequency of patients rather than treated as separate events
to prevent multiple counting of the same individual eg, to prevent individuals
who were intubated for over 12 hours and required post-extubation CPAP
being counted twice).
Abbreviations: CPAP, continuous positive airway pressure; NIV, noninvasive
ventilation; StEP, Standardized Endpoints for Perioperative Medicine.
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Escalation of respiratory support or invasive ventilation
beyond 12 hours after cardiac surgery was associated with
adverse clinical outcomes of increased mortality and pro-
longed ICU and hospital length of stay, which are outcomes of
interest to patients and relatives, as well as clinicians and
healthcare organizations. This was demonstrated in an unse-
lected patient population, which suggests that the StEP collab-
oration criteria combined with prolonged ventilation are useful
for routine surveillance, and may form the metric for quality
improvement work in this area. Unsurprisingly, within this
cohort, patients undergoing more complex surgery (as defined
by longer cardiopulmonary bypass time) and more comorbid
patients (higher EuroSCORE) were at higher risk of need for
escalation of respiratory support or prolonged invasive ventila-
tion, a finding that adds clinical plausibility to the measure.
It is likely that occurrence of escalation of respiratory support
reflects one or more severe postoperative pulmonary complica-
tions leading to severe respiratory insufficiency. The StEP Col-
laboration criteria for severity of respiratory complications after
surgery are objective measures that are not susceptible to crite-
ria based on a clinical diagnosis. Indeed, diagnosing pneumonia
can be complex, and simple factors such as not using chest radi-
ography routinely or changes in microbiological sampling tech-
niques can alter the reported rates of diagnosis.16
One retrospective study of 1,225 cardiac surgical patients
found that the rate of unplanned NIV use was 5.1%, which is
in line with the authors’ findings (6.0%). However, that studyhad a smaller sample size and reported reintubation rates in
the context of NIV failure only.17
The authors demonstrated that hypoxemia and anemia on
admission to ICU are associated with escalation of respiratory
support or prolonged invasive ventilation. The arterial partial
pressure of oxygen to inspired fraction of oxygen ratio has been
shown to predict mortality in the cardiac surgical setting.18 Its
usefulness as a predictor of escalation of respiratory support or
prolonged invasive ventilation has not been described before.
Perioperative anemia, defined as hemoglobin <100 g/L, leads
to a 3-fold increase in risk for postoperative pulmonary compli-
cations, independent of type of surgery.19,20 Anemia in the con-
text of cardiac surgery is associated with adverse postoperative
outcomes, although in moderate- to high-risk cardiac surgical
patients, restrictive transfusion strategies (hemoglobin<75 g/L)
are noninferior to liberal transfusion thresholds.21-23 The causal
link between postoperative anemia and respiratory complica-
tions after surgery is uncertain. However, one might hypothesize
that need for escalation of respiratory support or prolonged inva-
sive ventilation can be explained by higher blood transfusion
requirements in anemic patients, potentially resulting in transfu-
sion-related lung injury or circulatory overload.24,25 Of note, it
was impossible to include intraoperative ventilatory variables,
like PEEP, or other parameters of pulmonary mechanics, such
as driving pressure or mechanical power, because these data
were not available. Future studies should aim to obtain such
data as they may be significant predictors of respiratory compli-
cations after surgery, and if so whether they are modifiable.
Several authors have reported outcomes related to prolonged
invasive ventilation after cardiac surgery and developed prediction
models mainly using 24-, 36-, or 48-hour thresholds for prolonged
invasive ventilation.26-33 The standard definition of prolonged
invasive ventilation according the Society of Thoracic Surgeons is
a duration exceeding 24 hours.13 It has been shown that “time to
extubation” after cardiac surgery longer than 16 hours predicts
poor clinical outcomes (morbidity, mortality, and reintubation)
and that liberation from the ventilator within the first 9 hours is a
predictor of better postoperative outcomes.34-36 Recent evidence
suggests that extubation after 12 hours is associated with poor out-
comes and that major morbidity, operative mortality, and pro-
longed length of stay after cardiac surgery do not significantly
increase until “time to extubation” exceeds 12 hours.8-10 On this
basis, here the 12-hour benchmark was incorporated as an indica-
tor of prolonged invasive ventilation into the composite.
In addition to prolonged cardiopulmonary bypass time and aor-
tic cross-clamp time (known risk factors for prolonged invasive
mechanical ventilation beyond 24 hours), anemia and hypoxemia
on admission to ICU were identified as risk factors for prolonged
invasive ventilation.37-40 As an observational study the authors
cannot determine the mechanisms that lead to the associations
found; however, from the literature the authors can hypothesize
that long cardiopulmonary bypass time can lead to pulmonary dys-
function and need for prolonged invasive ventilation through
the following mechanisms: systemic inflammatory response and
activation of proinflammatory cytokines leading to endothelial
damage, increased pulmonary capillary permeability, and extravas-
cular lung water affecting lung compliance and gas exchange.41
Table 3
Characteristics of Patients Requiring Escalation of Respiratory Support or Invasive Mechanical Ventilation for More than 12 Hours After Exit From Operation
Room Versus the Rest of the Cohort
Variable Escalation of Respiratory Support12 (n = 510) No Escalation of Respiratory Support (n = 1,588) p Value
Surgical characteristics
Type of surgery
CABG 211 (41%) 708 (45%)
Valve surgery 159 (31%) 627 (40%)
CABG and valve surgery 140 (28%) 253 (16%) <0.001
Cardiopulmonary bypass time (min) 92.5 (73-120) 84 (66-101.5) <0.0001
Cross-clamp time (min) 61 (47-82) 56 (44-70) <0.0001
Patient characteristics
Age (y) 71.5 (10.4) 69.2 (10.8) <0.0001
Sex
Male 357 (70%) 1,588 (72%)
Height (m) 1.69 (0.10) 1.70 (0.10) 0.0989
Weight (kg) 83 (71-97) 81 (71-92) 0.0247
BMI (kg/m2) 29.4 (6.0) 28.2 (4.9) <0.0001
Hemoglobin (g/L) mean (SD) 99.8 (17.2) 104.6 (15.2) <0.0001
Logistic EuroSCORE 5.1 (2.5-9.2) 3.7 (2.1-6.7) <0.0001
Additive EuroSCORE 6 (4-8) 5 (3-7) <0.0001
PaO2:FIO2 ratio 30.5 (22.1-39.0) 35.3 (28.4-42.7) <0.0001
Outcomes
ICU length of stay (d) 2.1 (1.0-4.9) 0.9 (0.80-1.0) <0.0001
Hospital length of stay (d) 10.6 (8.0-16.0) 7.2 (6.2-10.0) <0.0001
Time to extubation (h) 23 (14-61) 5 (3-7) <0.0001
In-hospital mortality 15 (2.9%) 1 (0.1%) <0.001
NOTE. Data are mean (SD), number (%), or median (interquartile range). The reported p values were derived from t test (means), Wilcoxon rank sum test
(medians), and x2 test (categorical data).
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; EuroSCORE, European System for Cardiac Operative Risk Evaluation; ICU, intensive
care unit; SD, standard deviation; PaO2:FIO2 ratio, ratio of arterial partial pressure of oxygen to inspired fraction of oxygen.
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time and delayed extubation could reflect pulmonary microvascu-
lar dysfunction, although the mechanistic link between ischemia-
reperfusion and lung injury is not well understood. It is assumed
that it is related to an increase in pulmonary vascular resistance
and capillary permeability caused by prostaglandins, free radicals,
and complement activation.42 The association between postopera-
tive anemia and prolonged ventilation may reflect postoperativeFig 2. Time to event curves for patients with and without the composite outcome (
(B) Time alive and remaining in intensive care unit. (C) Time alive and remainin
unplanned continuous positive airway pressure, noninvasive ventilation or reintub
mechanical ventilation for more than 12 hours after exit from operation room. ICU,bleeding and, as a result, maintenance of sedation and invasive
ventilation in case reoperation is needed. Hypoxemia may be
owing to one or more postoperative pulmonary complications (eg,
atelectasis, ventilator-induced lung injury). Hypoxemia would
ordinarily delay tracheal extubation until lung tissue is re-recruited
and oxygenation is considered adequate.
The strengths of the present study lie in using a large dataset
with high level of completeness, the fact that there was noPanels A-C). (A) Time alive whilst receiving invasive mechanical ventilation.
g in hospital. Escalation of respiratory support (StEP criteria) was defined as
ation, and invasive ventilation. Prolonged ventilation was defined as invasive
intensive care unit; StEP, Standardized Endpoints for Perioperative Medicine.
Fig 3. Time to event curves for patients with and without StEP-defined pulmonary complications (Panels A-C) and for patients receiving immediate postoperative
invasive mechanical ventilation for >12 and <12 hours (Panels D-F). (A) and (D) Time alive whilst receiving mechanical ventilation. (B) and (E) Time alive and
remaining in intensive care unit. (C) and (F) Time alive and remaining in hospital. Escalation of respiratory support (StEP criteria) was defined as unplanned con-
tinuous positive airway pressure, noninvasive ventilation or reintubation, and invasive ventilation. Prolonged ventilation was defined as invasive mechanical venti-
lation for more than 12 hours after exit from operation room. ICU, intensive care unit; StEP, Standardized Endpoints for Perioperative Medicine.
Table 4
Univariable and Multivariable Regression of Risk Factors for Postoperative Escalation of Respiratory Support (StEP Criteria)
Univariate Analysis Included in Multivariate Multivariate Analysis
Variable of Interest Unadjusted odds ratio (95% CI) p Value Model (p < 0.15) Odds ratio (95% CI) p Value
Age 1.00 (0.99-1.02) 0.669 No - -
Sex (male = 1) 1.34 (0.91-1.97) 0.137 Yes 0.98 (0.56-1.70) 0.930
Height 2.52 (0.44-14.42) 0.299 No - -
Weight 1.03 (1.02-1.04) <0.001 Yes 1.01 (0.99-1.03) 0.381
BMI 1.10 (1.07-1.13) <0.001 Yes 1.03 (0.96-1.11) 0.380
Hemoglobin 0.99 (0.98-1.00) 0.096 Yes 0.98 (0.97-0.99) 0.002
Type of surgery - - Yes - -
CABG Ref Ref - Ref Ref
Valve surgery 0.49 (0.33-0.73) 0.001 - 0.67 (0.41-1.09) 0.108
CABG and valve surgery 1.03 (0.68-1.55) 0.890 - 0.76 (0.43-1.33) 0.339
Logistic EuroSCORE 1.01 (0.98-1.04) 0.322 No - -
Additive EuroSCORE 1.02 (0.96-1.08) 0.625 No - -
Cardiopulmonary bypass time 1.01 (1.00-1.01) <0.001 Yes 1.00 (0.99-1.02) 0.478
Cross-clamp time 1.01 (1.00-1.01) 0.005 Yes 1.00 (0.98-1.02) 0.865
HFNO 0.97 (0.13-7.28) 0.979 No - -
PaO2:FIO2 ratio 0.90 (0.89-0.92) <0.001 Yes 0.91 (0.89-0.93) <0.001
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; CI, confidence interval; EuroSCORE, European System for Cardiac Operative Risk
Evaluation; HFNO, high-flow nasal oxygen; PaO2:FIO2 ratio, arterial partial pressure of oxygen to inspired fraction of oxygen ratio; Ref, reference; StEP,
Standardized Endpoints for Perioperative Medicine.
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Table 5
Univariable and Multivariable Regression of Risk Factor for Prolonged Invasive Ventilation
Univariate Analysis Included in Multivariate Multivariate Analysis
Variable of Interest Unadjusted Odds Ratio (95% CI) p Value Model (p < 0.15) Odds Ratio (95% CI) p Value
Age 1.02 (1.01-1.03) <0.001 Yes 1.00 (0.98-1.01) 0.666
Sex (male = 1) 0.89 (0.71-1.11) 0.284 No - -
Height 0.37 (0.13-1.08) 0.069 Yes 0.75 (0.00-303.0) 0.926
Weight 1.01 (1.00-1.01) 0.016 Yes 1.00 (0.94-1.06) 0.967
BMI 1.04 (1.02-1.06) <0.001 Yes 1.03 (0.87-1.22) 0.726
Hemoglobin 0.98 (0.97-0.99) <0.001 Yes 0.98 (0.97-0.99) <0.001
Type of surgery Yes - -
CABG Ref Ref - Ref Ref
Valve surgery 0.88 (0.69-1.11) 0.294 Yes 0.96 (0.68-1.34) 0.796
CABG and valve surgery 1.99 (1.53-2.59) <0.001 Yes 1.10 (0.74-1.65) 0.613
Logistic EuroSCORE 1.06 (1.04-1.08) <0.001 Yes 1.03 (0.99-1.07) 0.109
Additive EuroSCORE 1.15 (1.10-1.19) <0.001 Yes 1.08 (0.96-1.21) 0.214
Cardiopulmonary bypass time 1.01 (1.01-1.02) <0.001 Yes 1.02 (1.01-1.03) <0.001
Cross-clamp time 1.01 (1.01-1.02) <0.001 Yes 0.99 (0.98-1.00) 0.032
PaO2:FIO2 ratio 0.96 (0.95-0.97) <0.001 Yes 0.96 (0.95-0.97) <0.001
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; CI, confidence interval; EuroSCORE, European System for Cardiac Operative Risk
Evaluation; PaO2:FIO2 ratio, arterial partial pressure of oxygen to inspired fraction of oxygen ratio; Ref, reference.
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measures with minimal scope for subjectivity, and the excellent
follow-up rates. In addition, the authors were able to conduct
internal validation of their predictive model using bootstrapping
demonstrating internal reliability of their findings.
Certain limitations to this study should be acknowledged.
First, its retrospective design renders the study susceptible to
selection bias and only routinely recorded data were available,
limiting the authors’ ability to analyze factors such as intraopera-
tive ventilation, or report on individual postoperative pulmonary
complications (atelectasis, pneumonia, acute respiratory distress
syndrome, pulmonary aspiration).1,2 In addition, owing to the
observational nature of the study, it was not possible to control
for clinical decision-making; however, agreed standards and pro-
tocol-driven care minimize variations in individual practice
within the institution where this study took place. In the authors’
modeling examining the length of stay, they were unable to
account for early mortality in both groups. Although, the number
of patients who died during the study period was low (n = 16),
this may introduce a possible censoring bias that should be con-
sidered in studies. Second, the study was undertaken at a large
volume cardiothoracic center, and the risk factor analysis was
not externally validated on other data sets; therefore, the authors’
results are not necessarily generalizable nor transportable to
other settings or geographic areas. Third, it was not possible to
include fluid balance, volumes, and types of transfused blood
products, hemodynamic variables, or vasoactive drug data that
could potentially be related to risk factors causing planned or
unplanned prolonged invasive ventilation (eg, delayed extuba-
tion owing to significant hemodynamic instability, hemorrhage,
and/or high vasoactive drug requirements or volume overload
affecting gas exchange) and escalation of respiratory support (in
cases of low cardiac output state and cardiac failure). Finally,
other confounding factors such as perioperative respiratory tract
infections, heavy smoking history, pre-existing lung disease,43
acute onset atrial fibrillation, slow recovery from anesthesia, oracute neurologic deficit potentially could have a hidden effect on
the authors’ collapsed composite outcome.
Having validated the StEP criteria for severity of postopera-
tive pulmonary complications in a cardiac surgical population,
the authors propose a number of possible uses for this approach.
The key question is whether pulmonary complications after sur-
gery are preventable, and if so whether their prevention improves
patient-focused outcomes. Potential interventions to test include:
early extubation thresholds (eg, 6 or 12 hours), as recent data
suggested no detrimental effect of extubation by 6 hours,8,10
perioperative oxygenation targets, effect of perioperative transfu-
sion strategies and intraoperative ventilatory strategies, including
PEEP and alveolar recruitment maneuvers. If the authors’ risk
adjustment is validated in subsequent studies, it may offer a
method for producing risk-adjusted postoperative pulmonary
complication rates allowing effective prospective comparison
within and between units, facilitating the use of postoperative
pulmonary complications rates as a quality measure.Conclusion
In a low- to medium-risk patient population undergoing rou-
tine cardiac surgery, escalation of respiratory support or pro-
longed invasive ventilation are associated with adverse
outcomes. Hypoxemia and anemia after cardiac surgery are
potentially modifiable risk factors for pulmonary complica-
tions, which need to be addressed better in future studies.Acknowledgments
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